Redmile Group, LLC Neuronetics, Inc. Transaction History

Redmile Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.22 - $15.54 $2.45 Million - $6.13 Million	-394,355 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$10.15 - $17.25 $1.07 Million - $1.82 Million	-105,645 Reduced 21.13%	394,355 $6.32 Million
Q1 2021 May 17, 2021	BUY	$10.6 - $21.27 $5.3 Million - $10.6 Million	500,000 New	500,000 $6.19 Million
Q4 2018 Feb 14, 2019	SELL	$16.0 - $31.84 $2.9 Million - $5.76 Million	-180,999 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$24.32 - $37.54 $2.89 Million - $4.47 Million	-119,001 Reduced 39.67%	180,999 $5.8 Million
Q2 2018 Aug 14, 2018	BUY	$26.61 - $27.78 $7.98 Million - $8.33 Million	300,000 New	300,000 $7.98 Million

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $46.2M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.